Design, synthesis, and biological action of 20 R -hydroxyvitamin D3

Journal of Medicinal Chemistry

Volumn 55, Issue 7, 2012, Pages 3573-3577

  Lu, Yan ^a   Chen, Jianjun ^a   Janjetovic, Zorica ^a   Michaels, Phillip ^a   Tang, Edith K Y ^b   Wang, Jin ^a   Tuckey, Robert C ^b   Slominski, Andrzej T ^a   Li, Wei ^a   Miller, Duane D ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYVITAMIN D3; CALCITRIOL; COLECALCIFEROL DERIVATIVE; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG MECHANISM; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ISOMER; STRUCTURE ACTIVITY RELATION;

EID: 84859801854     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm201478e     Document Type: Article

References (30)

1. Plum, L. A.; DeLuca, H. F. Vitamin D, disease and therapeutic opportunities Nat. Rev. Drug Discovery 2010, 9 (12) 941-955
2. Lappe, J. M. The role of vitamin D in human health: a paradigm shift J. Evidence-Based Complementary Altern. Med. 2011, 16, 58-72
3. DeLuca, H. F. Overview of general physiologic features and functions of vitamin D Am. J. Clin. Nutr. 2004, 80 (6, Suppl.) 1689S-16896S
4. Holick, M. F. Vitamin D Deficiency N. Engl. J. Med. 2007, 357, 266-281
5. Bouillon, R.; Okamura, W. H.; Norman, A. W. Structure-function relationships in the vitamin D endocrine system Endocr. Rev. 1995, 16 (2) 200-257
6. Pinette, K. V.; Yee, Y. K.; Amegadzie, B. Y.; Nagpal, S. Vitamin D receptor as a drug discovery target Mini-Rev. Med. Chem. 2003, 3 (3) 193-204
7. Takahashi, T.; Morikawa, K. Vitamin D receptor agonists: opportunities and challenges in drug discovery Curr. Top. Med. Chem. 2006, 6 (12) 1303-1316
8. Schwartz, G. G. Vitamin D and intervention trials in prostate cancer: from theory to therapy Ann. Epidemiol. 2009, 19 (2) 96-102
9. Slominski, A.; Semak, I.; Zjawiony, J.; Wortsman, J.; Li, W.; Szczesniewski, A.; Tuckey, R. C. The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism FEBS J. 2005, 272 (16) 4080-4090
10. Li, W.; Chen, J.; Janjetovic, Z.; Kim, T. K.; Sweatman, T.; Lu, Y.; Zjawiony, J.; Tuckey, R. C.; Miller, D.; Slominski, A. Chemical synthesis of 20 S -hydroxyvitamin D3, which shows antiproliferative activity Steroids 2010, 75 (12) 926-935
11. Guryev, O.; Carvalho, R. A.; Usanov, S.; Gilep, A.; Estabrook, R. W. A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1) Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (25) 14754-14759
12. Tuckey, R. C.; Li, W.; Zjawiony, J. K.; Zmijewski, M. A.; Nguyen, M. N.; Sweatman, T.; Miller, D.; Slominski, A. Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc FEBS J. 2008, 275 (10) 2585-2596
13. Slominski, A. T.; Janjetovic, Z.; Fuller, B. E.; Zmijewski, M. A.; Tuckey, R. C.; Nguyen, M. N.; Sweatman, T.; Li, W.; Zjawiony, J.; Miller, D.; Chen, T. C.; Lozanski, G.; Holick, M. F. Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity PloS One 2010, 5 (3) e9907
14. Zbytek, B.; Janjetovic, Z.; Tuckey, R. C.; Zmijewski, M. A.; Sweatman, T. W.; Jones, E.; Nguyen, M. N.; Slominski, A. T. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation J. Invest. Dermatol. 2008, 128 (9) 2271-2780
15. Janjetovic, Z.; Zmijewski, M. A.; Tuckey, R. C.; DeLeon, D. A.; Nguyen, M. N.; Pfeffer, L. M.; Slominski, A. T. 20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes PloS One 2009, 4 (6) e5988
16. Tocchini-Valentini, G.; Rochel, N.; Wurtz, J. M.; Mitschler, A.; Moras, D. Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands Proc. Natl. Acad. Sci. U.S.A. 2001, 98 (10) 5491-5496
17. Liu, Y. Y.; Collins, E. D.; Norman, A. W.; Peleg, S. Differential interaction of 1alpha,25-dihydroxyvitamin D3 analogues and their 20-epi homologues with the vitamin D receptor J. Biol. Chem. 1997, 272 (6) 3336-3345
18. Yang, W.; Freedman, L. P. 20-Epi analogues of 1,25-dihydroxyvitamin D3 are highly potent inducers of DRIP coactivator complex binding to the vitamin D3 receptor J. Biol. Chem. 1999, 274 (24) 16838-16845
19. Hansen, K. B.; Claus Aage, S. Vitamin D Analogues Containing a Hydroxy Group in the 20-Position. U.S. Patent US 5589471, 1996.
20. Mijares, A.; Cargill, D. I.; Glasel, J. A.; Lieberman, S. Studies on the C-20 epimers of 20-hydroxycholesterol J. Org. Chem. 1967, 32 (3) 810-812
21. Nes, W. R.; Varkey, T. E. Conformational analysis of the 17(20) bond of 20-keto steroids J. Org. Chem. 1976, 41 (9) 1652-1653
22. Komori, M. H. T. Structures of thornasterols A and B (biologically active glycosides from asteroidia, XI) Tetrahedron Lett. 1986, 27 (29) 3369-3372
23. Djerassi, C.; Staunton, J. Optical Rotatory Dispersion Studies. XLI. α-Haloketones (Part 9). Bromination of Optically Active cis -1-Decalone. Demonstration of Conformational Mobility by Rotatory Dispersion J. Am. Chem. Soc. 1961, 83, 736-743
24. Bartoszewicz, A.; Marcin, K.; Stawinski, J. Iodine-promoted silylation of alcohols with silyl chlorides. Synthetic and mechanistic studies Tetrahedron 2008, 64 (37) 8843-8850
25. Slominski, A. T.; Kim, T. K.; Janjetovic, Z.; Tuckey, R. C.; Bieniek, R.; Yue, J.; Li, W.; Chen, J.; Nguyen, M. N.; Tang, E. K.; Miller, D.; Chen, T. C.; Holick, M. 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells Am. J. Physiol.: Cell Physiol. 2011, 300 (3) C526-C541
26. Tuckey, R. C.; Li, W.; Shehabi, H. Z.; Janjetovic, Z.; Nguyen, M. N.; Kim, T. K.; Chen, J.; Howell, D. E.; Benson, H. A.; Sweatman, T.; Baldisseri, D. M.; Slominski, A. Production of 22-hydroxy metabolites of vitamin d3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells Drug Metab. Dispos. 2011, 39 (9) 1577-1588
27. Tang, E. K.; Li, W.; Janjetovic, Z.; Nguyen, M. N.; Wang, Z.; Slominski, A.; Tuckey, R. C. Purified mouse CYP27B1 can hydroxylate 20,23-dihydroxyvitamin D3, producing 1alpha,20,23-trihydroxyvitamin D3, which has altered biological activity Drug Metab. Dispos. 2010, 38 (9) 1553-1559
28. Tang, E. K.; Voo, K. J.; Nguyen, M. N.; Tuckey, R. C. Metabolism of substrates incorporated into phospholipid vesicles by mouse 25-hydroxyvitamin D3 1alpha-hydroxylase (CYP27B1) J. Steroid Biochem. Mol. Biol. 2010, 119 (3-5) 171-179
29. Slominski, A.; Zjawiony, J.; Wortsman, J.; Semak, I.; Stewart, J.; Pisarchik, A.; Sweatman, T.; Marcos, J.; Dunbar, C.; Tuckey, R. C. A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin Eur. J. Biochem. 2004, 271 (21) 4178-4188
30. Tuckey, R. C.; Nguyen, M. N.; Slominski, A. Kinetics of vitamin D3 metabolism by cytochrome P450scc (CYP11A1) in phospholipid vesicles and cyclodextrin Int. J. Biochem. Cell Biol. 2008, 40 (11) 2619-2626